《亞洲股市》臺股及日經跌1.1%及1.8% 港股跌幅曾擴至逾400點
美國3月ISM服務業指數及2月美國總貿赤數據均遜預期,加上歐美準備向俄羅斯實施更多制裁,以及聯儲局理事佈雷維德預期局方將迅速加息及縮表,美股結束兩連升,昨晚在重磅科技股領跌全面回吐0.8%-2.3%,Tesla(TSLA.US)回吐4.7%,暫停回購星巴克(SBUX.US)續跌4.5%,費城半導指數急吐4.5%,拖累納指跑輸急吐328點低收14,204;部分藍籌護理醫保股造好,道指及標指僅反覆回吐0.8%及近1.3%。此外,德意法股也低收吐近0.7%-1.3%;但富時及西班牙續升0.7%及1.2%,泛歐600續升0.2%。
美股期貨全面續軟,但跌幅均不足0.2%。亞太股市早段普遍受壓。美元兌日圓於亞洲續升0.3%報123.97,但日經連續兩天微彈後,今早急吐504點或1.8%報27,283即市低位。
澳洲200終止兩連升,最低見7,437,現報7,469,回吐0.8%。新西蘭50指數繼昨天回升0.6%後,今早回吐0.5%報12,056。南韓(KOSPI)連續兩天微彈後,今早回吐近0.7%報2,740。菲律賓(PSEI)續跌0.5%報7,117。
臺灣新冠疫情惡化,本土確診病例創新高,加權指數長週末假後復市延續上週尾兩連跌勢,報17,432,續跌1.1%。
滬指及深成長週末假後復市,扭轉上週五高收轉升0.9勢,分別低開0.4%及7點,報3,269及12,220,最低見3,263及12,148,現報3,276及12,191,回吐0.2%及0.3%。
港股繼週一高收續升462點或2.1%後,今早假後復市在阿裏巴巴(09988.HK)、美團(03690.HK)、網易(09999.HK)和京東(09618.HK)低開4%-5%,以及騰訊(00700.HK)和藥明生物(02269.HK)低開1.8%及2.2%主導,恆指低開282點或近1.3%報22,220,在公用和工商分類指數跌1.6%-2%,以及科指曾急吐3.6%拖累,跌幅曾擴至423點,最低見22,078,現報22,191,跌310點或1.4%。
新加坡海峽指數繼昨天回升0.8%後,現報3,434,回吐0.3%。然而,吉隆坡綜合指數逆彈0.2%報1,599。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.